Study of arundo muriatanica as a homoeopathic remedy for allergic rhinitis

A prospective interventional study on arundo in cases of allergic rhinitis - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075906

Enrollment

Registered

2024-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Arundo Muriatanica: Arundo Muriatanica 30 potency, twice a day for 15 days or when it is required. Control Intervention1: Not applicable, there is no comparator agent.: As Arundo Muriat

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients covering the diagnostic criteria for Allergic Rhinitis 2. Age – 18-50 years 3. Gender – both male and female 4. Patients having IgE level is greater than 140IU/ml 5. Patients having increased eosinophil count

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women 2. Cases of Sinusitis, Bronchial Asthma and Allergic Bronchitis will be excluded 3. Cases of Middle Ear Infections, Tonsillitis will be excluded

Design outcomes

Primary

Measure	Time frame
Betterment in health of patientTimepoint: 3 months	—

Secondary

Measure	Time frame
SFAR Scale Score less than 40 percentTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Munjal Thakar

Jawaharlal Nehru Homoeopathic Medical College

munjal.thakarahmc@paruluniversity.ac.in9227926514

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026